SCHEMBL8306860

SCHEMBL8306860

COc1ccc2[nH]cc(CCCN3CCC(CC(=O)c4ccc(F)cc4)C3)c2c1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.62
ACHE P22303 5/20 0.56
SLC6A4 P31645 3/20 0.55
SLC6A2 P23975 1/20 0.54
SLC6A3 Q01959 1/20 0.54
DRD2 P14416 1/20 0.53
BCHE P06276 2/20 0.50
ADRA2A P08913 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8306212 0.95 HTR2A (0.55) HTR1AACHESLC6A4DRD2BCHE
Hydrochloric Acid SCHEMBL9073679 0.94 HTR2A (0.54) HTR1AACHESLC6A4DRD2BCHE
SCHEMBL8310233 0.90 HTR1A (0.60) HTR1AACHESLC6A4DRD2
SCHEMBL8310519 0.84 NQO2 (0.46) HTR1ASLC6A4DRD2ADRA2AADRA1A
Hydrochloric Acid SCHEMBL8912255 0.83 NQO2 (0.45) HTR1ASLC6A4DRD2ADRA2AADRA1A
SCHEMBL8309219 0.82 HTR1A (0.65) HTR1AACHESLC6A4SLC6A2SLC6A3
SCHEMBL8307225 0.79 NQO2 (0.47) HTR1ASLC6A4DRD2
Hydrochloric Acid SCHEMBL8913070 0.78 NQO2 (0.46) HTR1ASLC6A4DRD2
SCHEMBL8306318 0.78 HTR1A (0.61) HTR1ASLC6A4SLC6A2SLC6A3DRD2
SCHEMBL8871079 0.76 HTR1A (0.63) HTR1ASLC6A4DRD2ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747379-B1 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia ADIR (FR) 1999-08-11 EP disclosed
EP-0747379-A1 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia ADIR ET COMPAGNIE (FR) 1996-12-11 EP disclosed